Northwire Canada EditionThursday, July 16, 2026
Sign inSubscribe
Northwire
⌕
CLCH 1.17 −4.1% DG 0.035 +0.0% SGML 15.86 −6.0% FURY 0.730 −2.7% CG 22.11 −1.9% ARIS 20.18 −1.1% LAF 1.65 +0.0% MKO 10.18 −2.2% NUG 0.330 −1.5% SGN 0.250 −5.7% AVL 7.99 −0.4% ELE 22.14 −2.7% TRX 1.03 −7.2% PTM 1.83 +0.6% OMM 0.050 −9.1% CBG 0.300 −1.6% CLCH 1.17 −4.1% DG 0.035 +0.0% SGML 15.86 −6.0% FURY 0.730 −2.7% CG 22.11 −1.9% ARIS 20.18 −1.1% LAF 1.65 +0.0% MKO 10.18 −2.2% NUG 0.330 −1.5% SGN 0.250 −5.7% AVL 7.99 −0.4% ELE 22.14 −2.7% TRX 1.03 −7.2% PTM 1.83 +0.6% OMM 0.050 −9.1% CBG 0.300 −1.6%
Financings

Rocket Doctor arranges $3-million private placement

By The Northwire Desk — AI Analysis Jan 09, 2026 · 15:21 AIDR · 0.76 Rocket Doctor AI Inc
AIDR · Price

Executive Summary

  • Rocket Doctor AI Inc. announced a non-brokered private placement under the Listed Issuer Financing Exemption (LIFE) to raise a minimum of approximately $3 million in gross proceeds.
  • The offering consists of 4,285,715 units priced at $0.70 per unit, with each unit comprising one common share and one warrant exercisable at $0.85 per share for a 12-month term.
  • Net proceeds will fund digital marketing, customer acquisition, R&D, operating expenses, and general working capital, with closing expected on or about January 19, 2026, subject to CSE approval and minimum subscription thresholds.

Key Details

  • Structure & Exemption: Non-brokered private placement completed under the Listed Issuer Financing Exemption (LIFE) per Part 5A of National Instrument 45-106.
  • Units Offered: Minimum of 4,285,715 units.
  • Price: $0.70 per unit.
  • Gross Proceeds: Minimum of approximately $3,000,000.
  • Unit Composition: Each unit consists of one common share and one common share purchase warrant.
  • Warrant Terms: Each warrant entitles the holder to purchase one common share at an exercise price of $0.85 per share for a period of 12 months following the closing date.
  • Hold Period: Units issued under the LIFE exemption are not subject to a statutory hold period under Canadian securities laws.
  • Finder’s Fee & Compensation: Up to 8% of aggregate gross proceeds payable as a finder’s fee, plus non-transferable warrants exercisable at $0.85 per share equal to 8% of the number of units issued, exercisable for 12 months from closing.
  • Use of Proceeds: Digital marketing, customer acquisition, operating and administrative expenses (including salaries), research and development, and general working capital.
  • Closing Date: On or about January 19, 2026.
  • Conditions Precedent: Receipt of minimum subscriptions totaling $3,000,000 and all necessary regulatory approvals, including Canadian Securities Exchange (CSE) approval.
  • Jurisdiction: Available to purchasers resident in all Canadian provinces except Quebec.
Read the original news release →

More from Rocket Doctor AI Inc

Jun 30, 2026 · 08:00

Rocket Doctor Enters into a Primary Care Value-Based Care Agreement in the United States, Expanding In-Network Coverage by More Than 5 Million Members

M&A / Property Jun 23, 2026 · 08:00

AI-driven telemedicine platform expanding U.S. payer network, but burning cash with a going concern warning.

M&A / Property Jun 18, 2026 · 08:00

AI-driven telehealth platform scaling U.S. payer network, but burning cash and diluting equity to fund marketing.

M&A / Property Jun 16, 2026 · 08:00

AI-driven telehealth platform scaling U.S. payer access while burning cash to fund growth and R&D.

Other Jun 08, 2026 · 08:00

Rocket Doctor AI Launches a Strategic Marketing Partnership with Rick Ware Racing and FINTEKK AP for the 2026 NASCAR Cup Series, NHRA (National Hot Rod Association), World Supercross Championship, AFT (AMA - American Flat Track) and other Nationally telev

M&A / Property Jun 02, 2026 · 08:00

AI Virtual Care Platform Accelerates U.S. Visits and Secures Cash Runway, But Margin Compression and Going Concern Doubts Loom

Earnings